Marco Antonio Perin
Marco Antonio Perin
Orientador da Pós Graduação Hospital Albert Einstein
Adresse e-mail validée de einstein.br
Titre
Citée par
Citée par
Année
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
MC Morice, PW Serruys, JE Sousa, J Fajadet, E Ban Hayashi, M Perin, ...
New England Journal of Medicine 346 (23), 1773-1780, 2002
51732002
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial
F Feres, RA Costa, A Abizaid, MB Leon, JA Marin-Neto, RV Botelho, ...
Jama 310 (23), 2510-2522, 2013
5672013
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry
HB Ribeiro, JG Webb, RR Makkar, MG Cohen, SR Kapadia, S Kodali, ...
Journal of the American College of Cardiology 62 (17), 1552-1562, 2013
3232013
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial
J Fajadet, MC Morice, C Bode, P Barragan, PW Serruys, W Wijns, ...
Circulation 111 (8), 1040-1044, 2005
3022005
Coronary obstruction following transcatheter aortic valve implantation: a systematic review
HB Ribeiro, L Nombela-Franco, M Urena, M Mok, S Pasian, D Doyle, ...
JACC: Cardiovascular Interventions 6 (5), 452-461, 2013
2082013
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death
M Urena, JG Webb, H Eltchaninoff, AJ Muñoz-García, C Bouleti, ...
Journal of the American College of Cardiology 65 (5), 437-448, 2015
1382015
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance …
J Mariani, C Guedes, P Soares, S Zalc, CM Campos, AC Lopes, ...
JACC: Cardiovascular Interventions 7 (11), 1287-1293, 2014
832014
Impact of Post Dilatation on the One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold
J de Costa, A Abizaid, A Bartorelli, R van Geuns, A Seth, P Serruys
Circulation 130 (Suppl_2), 2014
712014
Comparison of direct stenting versus stenting with predilation for the treatment of selected coronary narrowings
FS Brito Jr, AM Caixeta, MA Perin, M Rati, JA Arruda, M Cantarelli, ...
The American journal of cardiology 89 (2), 115-120, 2002
702002
The RAVEL study: a randomized study with the sirolimus coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions
PW Serruys, MC Morice, JE Sousa, J Fajadet, M Perin, E Ben Hayashi, ...
EUROPEAN HEART JOURNAL 22, 484-+, 2001
542001
Randomized evaluation of two drug‐eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare …
PA Lemos, B Moulin, MA Perin, LARR Oliveira, JA Arruda, VC Lima, ...
Catheterization and Cardiovascular Interventions 74 (5), 665-673, 2009
492009
SYNTAX score and long-term outcomes: the BARI-2D trial
F Ikeno, MM Brooks, K Nakagawa, MK Kim, H Kaneda, Y Mitsutake, ...
Journal of the American College of Cardiology 69 (4), 395-403, 2017
402017
Evaluation of plaque composition by intravascular ultrasound" virtual histology": the impact of dense calcium on the measurement of necrotic tissue.
FJ Sales, BA Falcao, JL Falcao, EE Ribeiro, MA Perin, PE Horta, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2010
392010
Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry
HB Ribeiro, L Nombela-Franco, AJ Muñoz-García, PA Lemos, ...
Journal of the American College of Cardiology 66 (19), 2075-2088, 2015
382015
Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention
M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ...
Journal of the American College of Cardiology 69 (2), 176-185, 2017
312017
The RAVEL study: a randomized study with the sirolimus coated BX velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions
JE Sousa, MC Morice, PW Serruys, J Fajadet, M Perin, EB Hayashi, ...
Circulation 104 (17), 463-463, 2001
282001
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design …
F Feres, RA Costa, DL Bhatt, MB Leon, RV Botelho, SB King III, ...
American heart journal 164 (6), 810-816. e3, 2012
272012
Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with de novo native coronary artery lesions
MC Morice
J Am Coll Cardiol 41, 32A, 2003
272003
Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patients
JR Cade, G Szarf, MEM de Siqueira, Á Chaves, JCM Andréa, HR Figueira, ...
European Heart Journal-Cardiovascular Imaging 18 (1), 54-61, 2017
252017
210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native …
J Fajadet, M Perin, EB Hayashi, A Colombo, G Schuler, P Barragan, ...
Journal of the American College of Cardiology 39 (Supplement 1), 20, 2002
242002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20